Bone Diseases, DevelopmentalBone Marrow TransplantationOsteosclerosisOsteochondrodysplasiasBone MarrowMucopolysaccharidosesTransplantation, HomologousBone Marrow CellsBone and BonesGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationSyndromeAnemia, AplasticBone RemodelingTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBone Marrow PurgingBusulfanHistocompatibility TestingBone DensityHematopoietic Stem CellsBone Marrow DiseasesHistocompatibilityCyclophosphamideTransplantation, IsogeneicKidney TransplantationMice, Inbred C57BLHematopoiesisRecurrenceBone ResorptionTreatment OutcomeBone Marrow ExaminationCombined Modality TherapyTime FactorsRadiation ChimeraLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsRemission InductionBone Marrow NeoplasmsGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseBone NeoplasmsFibrous Dysplasia of BoneLeukemia, MyeloidTransplantation ImmunologyAcute DiseaseGraft vs Host ReactionRetrospective StudiesImmunosuppressionStem Cell TransplantationLymphocyte DepletionBone DevelopmentLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationBone DiseasesT-LymphocytesSurvival AnalysisSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayHLA AntigensFollow-Up StudiesLung TransplantationCell DifferentiationHematologic DiseasesCyclosporineActuarial AnalysisEctodermal DysplasiaLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyPancytopeniaCarmustineSurvival RateLeukocyte CountFatal OutcomeBone RegenerationOrgan TransplantationCells, CulturedGraft vs Tumor EffectCytarabineMice, Inbred BALB CGraft vs Leukemia EffectCytomegalovirus InfectionsFlow CytometryBronchopulmonary DysplasiaGranulocyte Colony-Stimulating FactorSpleenMice, Knockout